SLC35A2 and metabolic dysfunction-associated steatotic liver disease: Similarly, the progression of human non-alcoholic fatty liver disease (NAFLD) is accompanied by a selective upregulation of certain UGT isoforms, notably UGT1A1, UGT1A3, UGT2B10, and UGT1A9 [53].